TLR2 and autoimmune disease: CAT predicts that the original mice will not experience either autoimmune disease or chronic inflammation whereas the third mouse will develop experimental autoimmune myocarditis and develop chronic inflammation driven specifically by TLR2, 4 and 7 and NOD2 (Table 1).